Clinical Trials Directory

Trials / Completed

CompletedNCT02465970

Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy

BRAINSTIM : Effects of Transcranial Direct Current Stimulation (TDCS) in Drug-resistant Partial Epilepsy

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
5 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

Drug-resistant partial epilepsy has a heavy impact on quality of life and sometimes on life expectancy itself. Only a minority of patients may benefit from a curative epilepsy surgery. Neurostimulation, which can be an effective add-on treatment, is currently mainly represented by vagus nervus stimulation. Transcranial direct current stimulation, a non -invasive technique already used in other areas of neurology, may be efficient on some partial epilepsies, in particular through the individual configuration of stimulation, made possible by recent technological advances. Main goal : To study the effect of transcranial electrical stimulation on the frequency of seizures in patients with drug-resistant partial epilepsy. Hypothesis : Reduction of 50% or more in the frequency of occurrence of seizures within 24 hours following an individually configured TDCS session: responders in real TDCS vs placebo stimulation.

Conditions

Interventions

TypeNameDescription
DEVICESTARSTIMMultifocal transcranial direct current stimulation. * CE-marked device, comprising a cap with 2 to 8 electrodes, connected with a programmable mobile stimulator. * The stimulation is applied during a 60 min session
DEVICEsham TDCS

Timeline

Start date
2015-11-13
Primary completion
2018-11-01
Completion
2018-12-01
First posted
2015-06-09
Last updated
2019-01-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02465970. Inclusion in this directory is not an endorsement.